COVID-19

Glaukos Announces Second Quarter 2024 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…

1 year ago

FendX Appoints Dr. Rohit Ramchandani, an Accomplished Public Health Expert, as Advisor

Dr. Ramchandani is a global expert in public health, infectious disease control, and policy implementation.He served as an advisor for…

1 year ago

Orbis’s Cybersight Platform Reaches 100,000 Registered Users and Receives $1 Million Donation

Eye care professionals from almost every country and territory across the globe—including nearly 15% of the world's ophthalmologists—have trained on…

1 year ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Organic revenue growth of +2.3% supported by both segments Care Delivery and Care EnablementOperating income1 and operating income margin1 increase…

1 year ago

Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer’s Patients

Two poster presentations at AAIC provide early evidence of the value of ultra-low-field Swoop® system MR brain images in ARIA-E…

1 year ago

Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer’s Patients

Two poster presentations at AAIC provide early evidence of the value of ultra-low-field Swoop® system MR brain images in ARIA-E…

1 year ago

IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001

Phase 2 OVATION 2 Study of IMNN-001 administered with standard-of-care chemotherapy as first-line treatment demonstrates a hazard ratio of 0.74…

1 year ago